ECONOMIC IMPLICATIONS OF BUDESONIDE MMX® ADVANTAGE IN ULCERATIVE COLITIS TREATMENT OVER SYSTEMIC STEROIDS- BUDESONIDE MMX® DECREASES ULCERATIVE COLITIS TREATMENT COSTS
May 1, 2016, 00:00
10.1016/j.jval.2016.03.983
https://www.valueinhealthjournal.com/article/S1098-3015(16)01051-2/fulltext
Title :
ECONOMIC IMPLICATIONS OF BUDESONIDE MMX® ADVANTAGE IN ULCERATIVE COLITIS TREATMENT OVER SYSTEMIC STEROIDS- BUDESONIDE MMX® DECREASES ULCERATIVE COLITIS TREATMENT COSTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01051-2&doi=10.1016/j.jval.2016.03.983
First page :
A314
Section Title :
Gastrointestinal Disorders - Cost Studies
Open access? :
No
Section Order :
1325